Cellular mechanisms of fatal respiratory insufficiency in arboviral encephalitis
Cellular mechanisms of fatal respiratory insufficiency in arboviral encephalitis
批准号:
8839829
负责人:
John D Morrey
金额:
$20.83万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-05-01 至 2016-04-30
关键词:
AMD3100AcuteArbovirus EncephalitisArbovirusesAreaBrainBreathingCD8B1 geneCXCL12 geneCXCR4 geneCell NucleusCellsCervicalCessation of lifeChemoreceptorsComplexD CellsDevelopmentDiseaseEncephalitisEventGenerationsGoalsHealthHumanHypercapniaImmuneInflammationInflammatoryInflammatory ResponseMicrogliaMusNeurologicNeuronsNeuropeptidesOutcomePatientsPenetrationPeptidesPhysiologicalPlayResearch Project GrantsRespirationRespiratory FailureRespiratory InsufficiencyRespiratory distressRespiratory physiologyRodent ModelRoleSomatostatinSomatostatin ReceptorStaining methodStainsT-LymphocyteTestingViralViral EncephalitisViral Load resultViral load measurementVirusWest Nile EncephalitisWest Nile virusbasechemokinedesigninfected vector rodentmacrophagenervous system disorderneurotropic virusoutcome forecastreceptorrespiratoryresponserestorationsomatostatin receptor 2virus envelope
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The overall goal is to identify the cellular mechanism of fatal respiratory insufficiency in arboviral encephalitides. Respiratory insufficiency is a serius outcome of arboviral encephalitis, and more specifically West Nile neurological disease, and can result in a poor prognosis. We have used rodent models to establish that neurological deficits cause the respiratory distress and are the primary pathophysiological mechanism of death for West Nile virus (WNV) and other viral encephalitides. These findings represent a breakthrough on how these viruses cause respiratory failure and death, but the cellular mechanism(s) causing these pathological responses are unknown, and are the subject of this application. The hypothesis to be tested is that the chemokine CXCR4/CXCL12 axis delays early entry of viral specific T lymphocytes into the parenchyma of the ventrolateral medulla (VLM) containing respiratory-control neurons. Additionally, we hypothesize that this delay results in higher virus load, and elevated inhibitory somatostatin (SST) neuropeptide or its receptor that contribute to lethal respiratory failure. This hypothesis is based on three recent findings. 1) Our finding that neurological respiratory insufficiency is a primary pathophysiologica mechanism of death in rodents infected with WNV and other arboviruses, which might be relevant to fatal viral encephalitides of human patients. 2) Remarkably, WNV envelope-immunostained neurons are tightly co-localized (96%) with SST-stained neurons in the VLM, which implies that WNV and/or inflammation are inducing SST. Specifically within the pre-B¿tzinger complex, an area critical for respiratory rhythmogenesis, there are many neurons heavily stained for SST. This may be biologically significant in WN neurological disease, because SST in the VLM is a potent negative regulator of breathing. Evidence that SST neuropeptide plays a role in the generation and control of respiration is based on profound negative respiratory effects caused by exogenously administered SST to the VLM, and a restoration of respiratory function by administration of antagonists to SST receptors. 3) CXCR4/CXCL12 axis delays entry of WNV-specific T lymphocytes from the perivascular spaces into the parenchyma of non-specified areas of the brain. Unfortunately, cytopathic neurotropic viruses, such as WNV, require penetration of viral specific CD8+ T cells into the parenchyma for clearance of the virus. This delay results in an increased viral load leading to increased inflammatory responses and decreased survival of WNV-infected mice. Consequently, the effect of delayed entry of protective T cells specifically in the VLM may aberrantly increase the SST inhibitory peptide under immune-pathological conditions and contribute to arboviral-induced respiratory failure. The specific aims designed to test the hypothesis are: Aim 1. Determine if delayed entry of WNV- specific T cells via the CXCR4/CXCL12 axis contributes to fatal respiratory insufficiency by increasing SST, and inflammatory cells specifically in the parenchyma of the VLM. We will accomplish this by quantifying inflammatory cells and SST in the VLM of WNV-infected mice with respiratory insufficiency, as compared to WNV-infected mice without respiratory insufficiency. Additionally, an antagonist of CXCR4 will be evaluated for its ability to mitigate these pathological events in the VLM. Aim 2. Determine if increased expression of SST or its receptor(s) is involved with WNV-induced respiratory insufficiency. This will be accomplished by determining if an antagonist to the SST receptor stereotaxically injected into the VLM can mitigate the effects of the virus to suppress respiratory functions.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Phrenic nerve deficits and neurological immunopathology associated with acute West Nile virus infection in mice and hamsters.
与小鼠和仓鼠急性西尼罗病毒感染相关的膈神经缺陷和神经免疫病理学。
DOI:
10.1007/s13365-016-0488-6
发表时间:
2017
期刊:
Journal of neurovirology
影响因子:
3.2
作者:
[Zukor,Katherine, Wang,Hong, Hurst,BrettL, Siddharthan,Venkatraman, VanWettere,Arnaud, Pilowsky,PaulM, Morrey,JohnD]
通讯作者:
Morrey,JohnD
TASK A87: Mouse Model for Testing of Influenza Vaccine Candidates
-
批准号:9149865
-
项目类别:
-
资助金额:$11.95万
-
财政年份:2015
-
负责人:John D Morrey
-
依托单位:
Identifying deficits in brainstem respiratory circuits during viral encephalitis
-
批准号:8970067
-
项目类别:
-
资助金额:$17.7万
-
财政年份:2015
-
负责人:John D Morrey
-
依托单位:
Task A66: Mouse Model of Low-pathogenicity Seasonal and Pandemic Influenza
-
批准号:9038198
-
项目类别:
-
资助金额:$0.18万
-
财政年份:2014
-
负责人:John D Morrey
-
依托单位:
Task A66: Mouse Model of Low-pathogenicity Seasonal and Pandemic Influenza
-
批准号:8930774
-
项目类别:
-
资助金额:$45.5万
-
财政年份:2014
-
负责人:John D Morrey
-
依托单位:
Cellular mechanisms of fatal respiratory insufficiency in arboviral encephalitis
-
批准号:8759225
-
项目类别:
-
资助金额:$17.36万
-
财政年份:2014
-
负责人:John D Morrey
-
依托单位:
Task A57: MOUSE MODEL FOR EVALUATION OF MEDICAL COUNTERMEASURES FOR MERS
-
批准号:9004295
-
项目类别:
-
资助金额:$2.55万
-
财政年份:2013
-
负责人:John D Morrey
-
依托单位:
Targeting induction of calcium buffer proteins for treatment of viral encephaliti
-
批准号:9108233
-
项目类别:
-
资助金额:$43.64万
-
财政年份:2012
-
负责人:John D Morrey
-
依托单位:
Targeting induction of calcium buffer proteins for treatment of viral encephaliti
-
批准号:8478041
-
项目类别:
-
资助金额:$19.27万
-
财政年份:2012
-
负责人:John D Morrey
-
依托单位:
Targeting induction of calcium buffer proteins for treatment of viral encephaliti
-
批准号:8892565
-
项目类别:
-
资助金额:$31.63万
-
财政年份:2012
-
负责人:John D Morrey
-
依托单位:
Targeting induction of calcium buffer proteins for treatment of viral encephaliti
-
批准号:8367065
-
项目类别:
-
资助金额:$19.27万
-
财政年份:2012
-
负责人:John D Morrey
-
依托单位:
Task A21: Small Animal Models for Biodefense Viruses
-
批准号:8844826
-
项目类别:
-
资助金额:$122.71万
-
财政年份:2011
-
负责人:John D Morrey
-
依托单位:
Task A21: Small Animal Models for Biodefense Viruses
-
批准号:9004347
-
项目类别:
-
资助金额:$126.45万
-
财政年份:2011
-
负责人:John D Morrey
-
依托单位:
Task A30:Mouse Models for Orthopoxviruses
-
批准号:8352205
-
项目类别:
-
资助金额:$25.6万
-
财政年份:2011
-
负责人:John D Morrey
-
依托单位:
Task A21: Small Animal Models for Biodefense Viruses
-
批准号:8352198
-
项目类别:
-
资助金额:$121.72万
-
财政年份:2011
-
负责人:John D Morrey
-
依托单位:
Pain Education
-
批准号:8355302
-
项目类别:
-
资助金额:$88.02万
-
财政年份:2011
-
负责人:John D Morrey
-
依托单位:
Treatment of acute west nile virus diease and neurological sequelea
-
批准号:8261428
-
项目类别:
-
资助金额:$31.37万
-
财政年份:2011
-
负责人:John D Morrey
-
依托单位:
Task A19 HUMAN HEPATITIS B VIRUS (HBV) MOUSE MODELS FOR TESTING HBV THERAPEUTICS
-
批准号:8891220
-
项目类别:
-
资助金额:$38.46万
-
财政年份:2010
-
负责人:John D Morrey
-
依托单位:
A15: Mouse Models for Influenza Vaccines
-
批准号:8352206
-
项目类别:
-
资助金额:$51.96万
-
财政年份:2010
-
负责人:John D Morrey
-
依托单位:
Task A37: Mouse Model for Influenza
-
批准号:8352203
-
项目类别:
-
资助金额:$85.4万
-
财政年份:2010
-
负责人:John D Morrey
-
依托单位:
Task A15: Mouse Models for Evaluation of Influenza Vaccines and Adjuvants
-
批准号:8891219
-
项目类别:
-
资助金额:$57.03万
-
财政年份:2010
-
负责人:John D Morrey
-
依托单位:
海外基金